Introduction
Adipose tissue is the largest energy reservoir of the human body ensuring homeostasis either by storing free fatty acids in the form of triglycerides or by hydrolysis of these stored products on demand. In addition, numerous adipokines are secreted from fat cells into the bloodstream and these bioactive molecules influence a wide range of metabolic functions such as energy balance, glucose oxidation, insulin sensitivity, host defense and reproduction. 1 Adipose tissue is mainly composed of terminally differentiated adipocytes filled with lipid droplets. These mature cells arise from preadipocytes, a fibroblast-like precursor cell present in the stromal-vascular fraction of the tissue. Recently, multipotent stromal cells with lineage potentials similar to bone marrow-derived mesenchymal stromal cells have been identified in adipose tissue, suggesting that this accessible and prevalent tissue could represent a promising alternative to bone marrow as a source of adult multipotent stem cells. 2, 3 These stem cells, as well as the more differentiated cell populations constituting adipose tissue, may represent appealing targets for therapeutic gene transfer.
Replication-defective herpes simplex virus (HSV)-based gene vectors are attractive vehicles for both ex vivo and in vivo gene transfer strategies. HSV vectors can be propagated to high titers on complementing cell lines, have large payload capacity and efficiently transduce cells at low multiplicity of infection (MOI). In addition to their natural tropism for neurons, HSV vectors can infect a wide variety of cell types including ligament, muscle, intestinal and bladder smooth muscle cells, suggesting that HSV may have broad utility for gene transfer applications. 4, 5 In the present study, we explored the feasibility of using genomic HSV-based recombinant vectors for gene transfer to adipose cells. Using an in vitro model that recreates adipose conversion, we demonstrated the presence of HveA and HveC HSV receptors and report efficient transduction of both human preadipocytes and mature adipocytes. Extended b-galactosidase (b-gal) expression and secretion of the exogenous gene product glial cell line-derived neurotrophic factor (GDNF) was demonstrated using explants of rabbit fat transduced ex vivo. Furthermore, direct inoculation of rabbit subcutaneous adipose tissue in vivo with an HSV vector expressing GDNF under the control of the LAP2-HCMV chimeric promoter resulted in local transgene expression persisting for at least 2 months.
Results

Presence of HSV entry receptors on adipose cells
An in vitro model of adipocyte differentiation from human precursor cells (Zen-Bio, Inc., NC, USA) 6 was initially used to evaluate the ability of replicationdeficient HSV vectors to infect adipose cells. These experiments employed primary human preadipocytes rather than the extensively studied 3T3-L1 murinetransformed cell line in order to gather insights that could prove relevant to human studies in the future. HSV recognizes two distinct receptors on susceptible cells termed herpesvirus entry mediators A and C (HveA and HveC). 7 HveA is a member of the TNF receptor family 8 and HveC has been identified as nectin-1a. 7, 9 Flow cytometry and indirect immunocytochemistry demonstrated that these receptors were present on the surface of both human preadipocytes and mature adipocytes following differentiation in vitro ( Figure 1 ). By flow cytometry, 2777% of cultured preadipocytes ( Figure 1a ) expressed HveA, while 9075% expressed HveC (Figure 1f ). Double-labeling experiments using both anti-receptor antibodies indicated that the HveApositive cells also expressed HveC on their surface (not shown). Nearly all mature adipocytes differentiated in vitro expressed both HveA (Figure 1b) and HveC ( Figure  1g) 10 The EGFP reporter gene was used to monitor infected cells in culture and quantify cell transduction by flow cytometry, while b-gal detection readily identified infected cells in intact fat tissue. Figure 2a shows high-level QOZHG-mediated EGFP expression in human preadipocytes. Flow cytometry of these cells infected at low multiplicity (MOI of 3) revealed that 9571% were transduced 2 days after infection (data not shown). Similarly, primary stromalvascular cells extracted from rabbit adipose tissue, expanded in culture and infected with virus ( Figure 2c ) revealed that 9371% of these cells expressed b-gal after X-gal staining, demonstrating that adipocyte precursors of different origin were similarly susceptible to HSV infection as determined by two independent methods of assessing transduction efficiency. At an MOI of one, 62% of the rabbit preadipocyte population expressed detectable transgene product, confirming that one infectious particle was sufficient to transduce a single cell in accordance with Poisson statistics.
Human preadipocyte cultures were induced to differentiate using a cocktail of adipogenic hormones, and subsequent infection showed the presence of numerous EGFP-fluorescent lipid-filled cells (Figure 2e ), representing nearly the entire adipocyte population. A subpopulation of adipocytes (B10-20%) remained EGFP positive 12 days after infection, the latest time point evaluated (data not shown).
Residual vector cytotoxicity on adipose cells in vitro
MTT assay was used to measure the metabolic activity of infected cultures as an indicator of vector toxicity. Cultured human preadipocytes and Vero cells were infected at an MOI of 3 with the QOZHG vector, and the cellular metabolic activity was measured at days 2 and 4 post-infection (Figure 3a) . At 2 days after transduction, the QOZHG vector was less cytotoxic for HSV transduction of adipose cells J Fradette et al preadipocytes (80% viable) than Vero cells (61%), a simian kidney cell line routinely used for HSV propagation. At 4 days after infection, 50% of the human preadipocytes remained metabolically active ( Figure  3a) . However, vector-related cytotoxicity was sufficient to prevent infected preadipocytes from differentiating into mature fat cells, a process requiring 2 weeks of culture under adipogenic conditions (data not shown). QOZHG infection of in vitro differentiated mature adipocytes also led to declining cell viability but this effect was more protracted than observed for subconfluent preadipocyte cultures (data not shown).
Considering that ICP0, the only HSV IE gene expressed in the vector, is known for its ability to alter cell functions, 11, 12 we examined the presence and distribution of this protein in the transduced cells by immunocytochemistry (Figure 3b-g ). Early after infection (9-24 h), ICP0 was observed in an intranuclear punctate staining pattern within infected preadipocytes ( Figure  3b ), a distribution characteristic of HSV infection of nonneuronal cells. 10 This punctate ICP0 staining expanded into the cytoplasm over time (Figure 3d ). In QOZHGtransduced human adipocytes differentiated in vitro, ICP0 was detected in the nucleus as early as 9 h postinfection and staining of the entire cell was seen from day 1 (Figure 3f ) until day 4 post-infection. Although ICP0 is known to have toxic effects on dividing cells, 13 it is likely that this viral function mediates cytotoxic effects on both dividing preadipocytes and quiescent adipocytes.
Ex vivo transduction of adipose tissue explants by HSV replication-defective vectors
Since HSV efficiently transduced adipocytes in monolayer culture, experiments were carried out to determine whether fat cells in intact tissue explants were also susceptible to virus-mediated transduction. Dorsal adipose tissue excised from rabbits was divided into fragments (B0.6 g each), injected with the QOZHG vector in vitro, and maintained as explants floating in adipocyte culture media (Figure 4a-f) . X-gal staining was 
HSV-mediated in vivo transduction of rabbit subcutaneous adipose tissue
The prolonged expression of b-gal in fat tissue samples ex vivo prompted further examination of fat transduction using an in vivo route of administration. The QOZHG vector was injected directly into the abundant and easily accessible subcutaneous dorsal fat pad of rabbits. Vector inoculation (2 Â 10 8 total particles in PBS) was performed in 7-8 injections for a total volume of 150 ml. Detection of b-gal expression was carried out by X-gal staining of the total adipose tissue at different time points. At 2 days after infection, the QOZHG-injected regions showed high levels of b-gal activity (Figure 5b . This observation suggested that the decline in b-gal expression was due to gradual silencing of the ICP0 IE promoter that controls lacZ expression rather than to loss of viral genomes.
HSV-mediated GDNF expression from adipose cells
Given that direct inoculation of fat tissue in vivo resulted in the accumulation of transgene product in adipose cells, a potential use of fat transduction might involve the synthesis of a therapeutic product suitable for release into the circulation. Accordingly, we examined the capacity of adipose cells to secrete a transgene product, glial cell line-derived neurotrophic factor (GDNF), which is a potent neurotrophin capable of supporting neuron survival in culture. 14 We recently reported that a component of the viral latency promoter, latencyassociated transcript 2 (LAP2), provides long-term transgene expression in neurons. 15 Moreover, the activity of LAP2 can be enhanced when used in combination with a strong promoter such as the HCMV IE gene promoter (SH and WFG, unpublished data). Thus in our current study, we engineered a new double gene vector, QL2HGDNF, in which the GDNF cDNA was placed under transcriptional control of a chimeric LAP2-HCMV promoter in the UL41 locus and the EGFP reporter gene driven by the HCMV IE promoter was retained in the deleted ICP27 locus (Figure 6a ). This new vector was examined for its ability to provide sustained production of GDNF in adipose cells.
We first compared human adipocyte cultures differentiated in vitro and their undifferentiated precursors for GDNF secretion after infection with QL2HGDNF or the QOZHG control vector (MOI ¼ 5) (Figure 6b ). High amounts of GDNF were released into the culture media from either cell type for at least 10 days following QL2HGDNF infection. The secretion levels obtained from mature adipocytes were approximately three-fold higher than from preadipocytes during the first week post-infection (Figure 6b) .
The ex vivo rabbit fat explant model was then used to determine whether inoculated intact fat tissue was capable of secreting GDNF in a dose-dependent manner. Explants injected with a range of vector doses (2 Â 10 5 , 2 Â 10 6 or 2 Â 10 7 total particles) demonstrated high levels of secreted GDNF for each set of explants ( Figure 7 ). Both the persistence and level of GDNF expression were dosedependent. The high-dose samples (2 Â 10 7 PFU) peaked at 2500 pg of GDNF/mg of protein on day 2. The In vivo experiments were conducted in which rabbit dorsal subcutaneous fat tissue was injected with either the QL2HGDNF or control vector, and the presence of GDNF in fat tissue extracts was compared to extracts from untreated animals. Vector preparations (2 Â 10 8 total particles in PBS) were administered at 7-8 injection sites into the fat pad, which was later excised, divided into multiple samples (B1 g each) and analyzed at days 2, 42 and 57 after injection. The amount of GDNF present in these tissue extracts was determined by ELISA. Figure 8 depicts the GDNF content of each sample constituting the dorsal fat pad injected with QL2HGDNF at day 2 (a), 42 (b) or 57 (c). The dotted zone on graphs b and c represents the baseline range of GDNF values measured for adipose tissue from mock-injected animals. No significant differences in GDNF concentrations were seen between tissues from noninjected or control vector QOZHG-injected animals (P40.05, Mann-Whitney test). At 2 days after transduction, high amounts (10-fold above baseline levels) of vector-derived GDNF were measured (Figure 8a, Po0.001). The highest GDNFexpressing samples (up to 6.8 ng GDNF/mg total proteins) likely corresponded to the injected sites. At 42 days post-injection (Figure 8b ), GDNF levels were considerably reduced (80% reduction compared to day 2; Po0.01) but were still higher on average than values obtained from mock-injected animals (Po0.05). Adipose tissue harvested 57 days after injection (Figure 8c ) also displayed greatly reduced GDNF levels compared to day 2 (Po0.05) but was still positive for GDNF expression (Po0.001). Expression at day 57 still represented 20% of the initial expression level, was not different from GDNF levels seen at day 42 (P40.05), and corresponded to a two-fold increase over baseline.
The presence of viral genomes in DNA extracted from these samples was investigated by PCR, as before. Samples from QL2HGDNF-injected animals were positive at each time point analyzed (Figure 8d ). Table 1 shows that the percentage of vector genome-positive samples was consistent for all three sampling times and represents approximately 40% of the injected fat pad. Of the genome-positive samples, the percentage of GDNFcontaining extracts declined from approximately 80% at day 2 to 50% at day 57, a proportion higher than that observed for b-gal expression from QOZHG. This finding may be related to the sensitivity of the detection method of the two transgene products, the nature of the transgenes or to the behavior of the two different promoters used to drive transgene expression. In either case, the reduction in transgene product over time was unlikely the result of extensive vector genome loss at the injected sites.
To determine if circulating levels of GDNF were achieved after vector injection, plasma samples from HSV transduction of adipose cells J Fradette et al the QL2HGDNF-injected rabbits were analyzed and compared to the QOZHG-injected and naive animals. The ELISA assay detected no increase in plasma GDNF levels above baseline values for any animal from 1 to 8 weeks after injection. To verify that an impairment in secretion in vivo was not responsible for the lack of GDNF detection in the serum, pieces of rabbit fat injected in vivo were excised 2 days post-injection, maintained in culture as explants and the levels of secreted GDNF measured ( Figure 9 ). Among the tissue fragments (n ¼ 5) obtained from the QL2HGDNF-injected animal, different expression profiles were observed, with high levels of expression (up to 1.1 ng/mg protein) for two fragments (GDNF-2 and -5). Others exhibited moderate (GDNF-4) to low (GDNF-1 and -3) GDNF secretion for up to 12 days in culture, after which the values returned to baseline levels measured for adipose tissue fragments (n ¼ 5) obtained from QOZHG-injected rabbit. These observations indicated that the absence of detectable GDNF in the circulation was unlikely the result of impaired GDNF secretion from adipose tissue transduced in vivo.
Discussion
Previously, we reported that an HSV-derived nerve growth factor (NGF) gene vector administered in vivo to inguinal adipose tissue resulted in sustained circulating levels of NGF that prevented peripheral nerve degeneration in a mouse model of diabetic neuropathy. 16 While these experiments pointed out that inoculation of murine fat tissue with recombinant HSV vectors could provide sustained expression of a secreted transgene product, the vector distribution or nature of the transduced cells remained to be characterized. The goals of the current study were to examine in detail the ability of HSV vectors possessing more extensive IE gene deletions to infect and transduce adipose cells derived from rabbits and humans, and to evaluate potential vector-related toxicity, genome persistence and durability of transgene expression. We demonstrate here for the first time that both precursors and mature adipocytes of rabbit and human origin are readily transduced by recombinant genomic HSV-based vectors in vitro, requiring only a single infectious particle per cell to express and/or secrete detectable transgene products. Virus infectivity correlated with the presence of well-characterized HSV receptors (HveA and HveC) not previously shown to be present on adipose cells. Using b-gal and GDNF as transgene products, we observed GDNF secretion from adipose cells in vitro and local transgene expression in rabbit fat tissue following vector delivery in vivo. For example, at 2 days post-inoculation, the GDNF content of the dorsal fat pad injected with the GDNF gene vector was 10-fold higher than tissue inoculated with the control vector. However, the total amount of GDNF measured in the tissue represents only 30% of the amount predicted from our in vitro data. Approximately 40% of the tissue samples contained vector genomes (Table 1) , a finding consistent with transgene expression at the site of injection with limited virus diffusion to neighboring cells. Optimization of vector dosage and delivery will be needed to improve vector distribution and the outcome of transgene expression, particularly for applications involving larger animals.
Transduction of adipose cells with HSV vectors compares favorably to the data available from other vector systems. Although recombinant SIV vectors have recently been shown to infect human adipocytes, the efficiency was substantially lower, requiring an MOI of 5000 to infect approximately 60% of cells in culture. 17 Adenoviral-mediated gene transfer has also been demonstrated in differentiated adipocytes in vitro 18 and following adipose tissue injection in vivo, with transgene expression persisting for approximately 2 weeks. [19] [20] [21] [22] However, preadipocytes of either human or murine origin were not transduced unless either very high multiplicities were applied or the cells were modified to express the coxsackie-adenovirus receptor (CAR) normally lacking on the surface of preadipocytes. 22, 23 In contrast, retroviral-mediated transduction is limited to replicating preadipocytes, while nondividing adipocytes are not infected. 24 After cell transduction, the HSV genome persists as an intranuclear episomal element, 25 eliminating risks related to insertional mutagenesis. The efficiency of HSV infection allows for repeat vector dosing, a possibility that is difficult to achieve with other vector systems. 16, 26 Our previous results demonstrated that a replicationdefective HSV:NGF vector introduced into inguinal fat tissue of mice resulted in expression of NGF detectable in serum for 11 months. 16 In contrast, circulating vectorderived GDNF was not detected in rabbit plasma samples. While the precise reason for this outcome is unknown, the most likely explanation is that the rabbit study employed a vector dose that was 10 times lower on a per kilogram basis, resulting in plasma GDNF levels below the detection limit of the ELISA. Taking into account our previous data where only B10% of the transgene product expressed in rabbit tissue reached the bloodstream, 27 that a total of 26 ng/mg of GDNF was Figure 9 GDNF secretion from adipose tissue after in vivo transduction. Rabbit adipose tissue inoculated in vivo with QL2HGDNF or QOZHG was excised 2 days after injection, cut in B1 g fragments and maintained in culture as explants. GDNF secretion was monitored and quantified by ELISA assay and related to total protein concentration. QOZHG-injected explants served as controls (MOCK) to determine baseline values of GDNF (n ¼ 5). Different secretion profiles were observed among the five QL2HGDNF-derived explants. High amounts of GDNF (B1 ng/mg) were measured for explants GDNF-2 and -5 one day after establishment in culture (3 days post-inoculation), while moderate (GDNF-4) or low levels of GDNF were secreted by explants GDNF-1 and -3. GDNF production persisted for up to 12 days of culture after which GDNF levels reached baseline values.
HSV transduction of adipose cells J Fradette et al measured in the dorsal fat (representing 30% of the amount predicted from in vitro data), and that the volume of plasma for the animals used in these studies was 180 ml for rabbits and 800 ml for mice, the resulting plasma GDNF concentration fell below the detection limit of the ELISA (32 pg/ml). As mentioned, strategies to improve diffusion of the vector and overall transduction of voluminous fat pads may result in detectable serum levels. Other mitigating variables may include the short half-life of GDNF, the strength of the chimeric LAP2-HCMV promoter and the anatomical location of the targeted fat pad. We previously reported that HSV-mediated delivery of GDNF to the peripheral and central nervous system under control of the HCMV promoter was therapeutic in short-term models of spinal cord injury, neuropathic pain and Parkinson's disease, 26, 28 but long-term therapeutic gene expression was only achieved using the LAP2 promoter. 15 In our experience, the activity of this promoter in adipocytes is very low (JF, unpublished observation). However, LAP2 used in combination with a strong promoter such as HCMV has shown enhanced activity (SH and WG, unpublished data). Accordingly, we tested the LAP2-HCMV chimeric promoter to examine the possibility of prolonged transgene expression in adipose cells. We observed continued local GDNF production for at least 2 months in rabbit adipose tissue in vivo. However, initial high levels of transgene expression gradually declined during this time period, suggesting that LAP2 could not sustain maximum levels of transgene expression. Nevertheless, for highly active neurotrophins such as GDNF, this lower level of expression may be sufficient to achieve biological effects in vivo, as recently observed in rodent CNS models of Parkinson's disease. 15 Considerable progress has been made in reducing HSV vector-associated cellular toxicity. 11, 29 Among the immediate early genes that affect cell viability, the ICP0 gene product has been shown to arrest cell cycle progression and disrupt nuclear domain 10 structures that contain a number of cellular products including DNA repair functions, histone deacetylases and promyelocytic leukemia antigen (PML). [30] [31] [32] Additionally, ICP0 possesses ubiquitin ligase activity and has been shown to target particular cellular functions for proteosome degradation as a prelude to viral replication. 13 Mutant viruses that fail to express the IE genes including ICP0 are noncytotoxic, but their genomes are strongly repressed in standard fibroblast cultures and transgenes are rapidly silenced. 11 In contrast to the situation in nonneuronal cells, ICP0 is rapidly degraded in neurons, which may contribute to the ability of HSV to establish latency in these cells. 10 Based on the above considerations, we selected for the current study a mutant virus background that would provide the most efficient transduction and transgene expression. The highly defective vectors we used express a single viral function, ICP0, with previously unknown potential toxicity for nondividing, mature adipocytes. As observed with other cell types, 10 the ICP0 gene product accumulated in the nucleus of both preadipocytes and mature adipocytes with attendant cytotoxicity. Compared to adipocyte cultures, preadipocytes plated at low density were highly sensitive to the cytotoxic effects of ICP0, which included interference with both cell division and differentiation. In contrast, vector injections into adipose tissue in vivo suggested that intact fat tissue was more resistant to the toxic effects of this viral product since vector genome stability and persistent transgene expression were observed. While these in vivo findings may be more promising, it is clear that a better understanding of the role of ICP0 in preventing promoter silencing will be required to engineer vectors that are broadly applicable to non-neuronal cells.
The central role of obesity in the development of adult onset diabetes and cardiovascular diseases suggests that genetic modification of fat tissue will likely emerge as an important therapeutic strategy in the future. The feasibility of targeting adipose tissue is supported by several practical considerations. First, fat is found in most body locations under the skin surface and is readily accessible for nonsurgical vector administration. Second, fat is largely dispensable, allowing safe removal of the injected tissue in the event of a possible gene transferrelated adverse reaction. Third, fat is often well vascularized and secretes a wide range of molecules into the blood, providing opportunities to either supply therapeutic products to the circulation or alter adipose tissue metabolism locally. And fourth, multipotent precursor stem cells can be readily isolated from fat tissue with the potential for application to selected forms of tissue repair. Here, we provide evidence that HSV vectors may be developed for gene transfer to adipocytes and their precursors, which could ultimately translate into the development of new strategies for the treatment of obesity-related diseases.
Materials and methods
Cell culture
Human subcutaneous preadipocytes and culture media were purchased from Zen-Bio Inc. (Research Triangle Park, NC, USA) and cells were differentiated according to the provided instructions. Rabbit stromal-vascular cells were extracted from dorsal adipose tissue according to a modification of standard protocols 33, 34 and expanded in preadipocyte media. Briefly, rabbit fat was digested for 30 min at 371C in a 0.05% collagenase A (Roche, Indianapolis, IN, USA) solution containing 0.5 mM glucose (Sigma, St-Louis, MO, USA) and 4% bovine serum albumine (BSA, Sigma) in phosphate saline buffer (PBS). The resulting cellular suspension was filtered through a 250 mm tissue sieve, pelleted at 700 g for 10 min and contaminating red blood cells were eliminated by hypo-osmotic shock. Vero cells (African Green monkey kidney cells, ATCC (CCL81), Rockville, MD, USA) were grown in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Grand Island, NY, USA) supplemented with 5% fetal bovine serum (FBS, Sigma). CHO-HveA and CHO-HveC cells (kindly provided by Dr Patricia Spear, Northwestern University) were cultured in F-12K medium supplemented with 10% FBS, 100 U/ml Penicillin and Streptomycin and 250 mg/ml G418 (Invitrogen).
Flow cytometry analysis of HSV entry receptors
Human preadipocytes (passages 3-6) were analyzed for surface expression of the two HSV-1 receptors by flow cytometry (FACSCalibur, Becton-Dickinson, San Diego, HSV transduction of adipose cells J Fradette et al CA, USA). Cultured cells were trypsinized and stained with the following primary antibodies (Abs) diluted in PBS containing 1% FBS: R140, a rabbit antiserum directed against the HveA receptor (n ¼ 6) and two mouse monoclonal Ab directed against the human HveC molecule: CK6 (n ¼ 2) and CK41 (n ¼ 3) (kindly provided by Drs Gary Cohen and Roselyn Eisenberg, University of Pennsylvania). Secondary Abs included an FITC-conjugated goat anti-rabbit immunoglobulins (IgG) (Sigma) and a goat RPE-conjugated anti-mouse IgG (Dako, Denmark). For double-labeling experiments (n ¼ 2), biotinylated CK41 antibody was used in combination with a streptavidin-APC conjugated secondary antibody (Sigma). Negative controls were performed using secondary Abs only. Signal for nonspecific background was tested on Chinese Hamster Ovary (CHO) cells, while CHO cell lines expressing human HveC (M3A) and HveA (M1A) were used as positive controls.
Histochemistry
Cultured cells were fixed with 1% formol (Sigma) in PBS at room temperature for 5 min, then rinsed with PBS and permeabilized with methanol for 2 min at À201C. Indirect immunofluorescence staining was performed by first blocking with 10% horse serum (HS) (Invitrogen) in PBS for 30 min followed by incubation for 3 h at room temperature or overnight at 41C with primary antibody in PBS/1% FBS. Primary antibodies used were CK41 (40 mg/ml), CK6 (175 mg/ml), R140 (1:200) or the mouse anti-ICP0 mAb (1:5000, Virusys, East Coast Biologics Inc., North Berwick, ME, USA). Cells were then incubated with a Cy3-conjugated anti-mouse or anti-rabbit secondary antibody (1:500, Sigma) for 45 min at room temperature. Cells were observed with a Nikon Diaphot 300 inverted fluorescent microscope (Nikon Inc., Melville, NY, USA). 10,11 The construction of the GDNF expression vector QL2HGDNF was similar to QL2HNT-3, a vector with a chimeric LAP2/HCMV promoter driving NT-3 in the QOZHG backbone. 35 The rat GDNF PCR product 28 was ligated with XbaI linkers, digested with XbaI, and inserted into the XbaI site of the plasmid p41L2HlacZ to create p41L2HGDNF. Plasmid p41L2HlacZ contains a LAP2HCMVlacZ polyA cassette in which the lacZ sequences are flanked by XbaI sites. The entire expression cassette is flanked by HSV sequences nt. 90145-91605 and nt. 92193-93857. Plasmid p41L2HGDNF was cotransfected with QOZHG viral DNA and clear plaques were purified by three rounds of single plaque isolation 36 and the genetic structure confirmed by Southern blot analysis using GDNF and UL41-specific probes. Viral stocks were purified in a continuous nycodenze gradient (Optiprep, Life Technologies Inc., Gaithersburg, MD, USA), resuspended in PBS, aliquoted, stored at À801C and titered on 7b cells.
In vitro transduction of cultured cells and rabbit adipose tissue explants with replication-deficient HSV vectors
Subconfluent cell monolayers were infected with HSV vectors and analyzed at different times after infection. Transduction efficiency was quantified either by direct determination of the percentage of b-gal positive cells after X-gal staining of 0.25% glutaraldehyde-fixed cell monolayers or by flow cytometry of EGFP-expressing infected cells (FACSCalibur, Becton-Dickinson). The viability of infected cultures was evaluated by MTT (n ¼ 4) assays (Sigma). Adipose tissue derived from naive rabbits was cultured as explants (B0.6 g per sample) in 12-well plates containing 2-3 ml of adipocyte media (Zen-Bio). In vitro injection of the explants with HSV vectors was carried out with a 3/10 cc syringe in one 20 ml-injection containing the desired amount of viral particles.
Quantification of GDNF secretion after transduction
Quantification of GDNF production by transduced cultured cells and adipose tissue explants was measured in culture media using the GDNF Emax ImmunoAssay System (Promega, Madison, WI, USA). Supernatants were regularly harvested for quantification of transgene secretion by ELISA as well as protein content determination by MicroBCA assay (Pierce, Rockford, IL, USA). Samples from later time points of culture were concentrated using YM-10 centrifugal filter devices (Centricon, Millipore, Bedford, MA, USA).
In vivo transduction of rabbit adipose tissue with HSV vectors
New Zealand White rabbits (Myrtles Rabbitry, Thompson Station, TN, USA) were anesthetized with ketamine/ acepromazine and injected through the skin into the dorsal fat pad with 7-8 injections of 20 ml of vector diluted or not in PBS, for a total of 2 Â 10 8 particles (B160 ml) of Optiprep-purified vector. The animals were divided in two groups and compared to uninjected animals. One group received the QL2HGDNF vector encoding the secreted GDNF protein, while the control group received the QOZHG vector encoding the b-gal reporter gene. Blood samples were harvested each week and one animal per group was killed at day 2, day 42 and day 57 after infection. The entire dorsal fat pad was then excised, cut in B1 g fragments and processed for various analysis: some samples were (a) frozen in liquid nitrogen for protein, DNA and RNA extraction, (b) X-gal stained, (c) fixed in 10% formalin and embedded in OCT compound (Tissue-Tek, Sakura Finetek USA, Torrance, CA, USA) for cryosection (20 mm) analysis using the CryoJane s Tape-Transfer System or (d) cultured as explants in adipocyte media.
Assessment of transgene expression in adipose tissue
X-gal staining was performed on unfixed adipose tissue samples by overnight incubation at 371C in a solution of 1.1 mg/ml 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (Roche), 14.7 mM K 4 Fe(CN) 6 , 14.7 mM K 3 Fe(CN) 6 in 25 mM Tris buffer at pH 8. Total proteins were extracted from frozen adipose tissue of each rabbit by incubation (1:3 w:v ratio) for 2 h at 41C in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, HSV transduction of adipose cells J Fradette et al 1% Nonidet P-40, 1 mM PMSF and 5 mg/ml leupeptin) followed by sonication and centrifugation at 41C for 15 min at 2100 g (adapted from Nisoli et al
37
). The infranatants were kept at À801C for further analysis and GDNF ELISA quantification.
Nucleic acid isolation and analysis
Genomic DNA was isolated from rabbit adipose tissue fragments (B1 g) using a Qiagen DNeasy tissue Kit (Qiagen, Valencia, CA, USA). Frozen or protein-extracted adipose tissue samples were processed according to supplier's instructions. PCR analysis was performed on a Robocycler (Stratagene, La Jolla, CA, USA) with Taq platinum (Invitrogen) using 150 ng of genomic DNA from each sample in a reaction volume of 50 ml. The following primer pairs were used: (Primer1/Primer2 (product size, product identity, annealing temperatures)): U L 30U/U L 30L (479 bp, HSV U L 30, 63/581C), CAGTAC GGCCCCGAGTTCGTGAC/GTCGTAGATGGTGCGGG TGATGTT; LacZU/LacZL (535 bp, lacZ, 63/581C), CACC AGCAGCAGTTTTTCCAGTTCC/GGGTCGCTTCACTT ACGCCAATGT; RabGAPDHU/RabGAPDHL (262 bp, rabbit GAPDH 65/581C) TCTGGGAA-GCTGTGGCGTG AC/CCTCGGTGTAGCCCAGGATGC; GDNFU/GDNFL (289 bp, GDNF, 61/551C), ATGGCAGTGCTTCCTAGA AGAGAGC/AACATGCCTGCCCTACTTTGTCA; PCR conditions were as described with the appropriate annealing temperatures for each primer set. 27 The PCR reaction (12 ml) was subjected to electrophoresis on 1% agarose TBE/EtBr gels and images were acquired with a Kodak DC120 Scientific Imaging System (Kodak, Rochester, NY, USA).
RNA extraction and RT-PCR
Total RNA was extracted from rabbit adipose tissue, explants or cultured cells using an RNA/DNA tissue kit (Qiagen) following homogenization with a tissue homogenizer (Tissue tearer, Biospec Products Inc.). DNase I (Promega) treatment was performed on RNA samples to avoid genomic DNA contamination. A first-strand cDNA synthesis kit was used with Oligo dT primers (Invitrogen) to generate cDNAs. In all, 2 ml of the reaction mixture was amplified in a 50 ml PCR reaction with specific primers (20 pmol) and Taq Platinum Polymerase as described above in the presence or absence of reverse transcriptase.
Statistical analysis
Data is presented as mean7s.d. A two-tailed nonparametric Mann-Whitney test (GraphPadPrism3.0 software) was used for statistical comparisons between rabbits. Multiple groups were compared using the KruskalWallis test followed by Dunn's post-tests. In all statistical tests, the confidence interval was set at 95% (Po0.05).
